NewsStay Updated with the Latest News from 3billion.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.
3billion announces pathogenicity predictor ‘3Cnet’
News | 21. 07. 30
3billion looks to 2022 IPO, expansion into drug discovery
News | 21. 04. 19
Rare disease screening firm 3Billion closes $13M Series C financing
News | 21. 03. 26
3billion aims for the global market by IPO
News | 20. 10. 12
3billion Named “Next Unicorn” at ASEAN-Korea Scale-up Contest
News | 20. 09. 18
3billion CEO: “We diagnose 7,000 rare diseases at once using AI”
News | 20. 07. 25
